| Aleksey Brooke Green, | |
|
18905 33rd Ave W Ste 109, Lynnwood, WA 98036-4736 | |
| (425) 361-7046 | |
| (425) 249-3525 |
| Full Name | Aleksey Brooke Green |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 18905 33rd Ave W Ste 109, Lynnwood, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053982363 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SI61096767 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Aleksey Brooke Green, 18905 33rd Ave W Ste 109, Lynnwood, WA 98036-4736 Ph: (425) 361-7046 | Aleksey Brooke Green, 18905 33rd Ave W Ste 109, Lynnwood, WA 98036-4736 Ph: (425) 361-7046 |
News Archive
Harvard Medical School researcher Peter Kharchenko and three collaborators have won a six-year multimillion-dollar grant from the European Research Council for their work toward mapping out cellular decision-making during early development in an effort to illuminate new pathways for the treatment of pediatric cancer.
A groundbreaking piece of medical technology was revealed to the public today at the National Research Center for Cardiac Surgery in Astana, Kazakhstan. At a press conference held at the Center, top heart failure experts from around the world announced the successful implantation of FIVAD into a human.
Queen's University researcher Timothy Hanna has co-authored a Lancet Oncology study that suggests as many as 90 per cent of people in low-income countries lack access to radiotherapy treatment. The lack of access to radiotherapy costs millions of lives and billions of dollars in lost economic growth in low- and middle-income countries.
Juventas Therapeutics is a privately-held, clinical-stage company developing novel regenerative therapies for treatment of cardiovascular disease. The Company's lead product, JVS-100, encodes Stromal cell-Derived Factor 1 (SDF-1) which has been shown to repair damaged tissue through recruitment of circulating stem cells to the site of injury, prevention of ongoing cell death and restoration of blood flow.
A computerized model suggests that most morbidly obese individuals would likely live longer if they had gastric bypass surgery, according to a report in the January issue of Archives of Surgery, one of the JAMA/Archives journals. However, the best decision for individual patients varies based on factors such as age, increasing body mass index and the effectiveness of surgery.
› Verified 3 days ago
Carole Barbara Scandella, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20420 68th Ave W, Lynnwood, WA 98036 Phone: 425-431-7180 | |
Robert Thomas Morton, M.S., SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20818 44th Ave W # 270-b, Lynnwood, WA 98036 Phone: 425-672-9219 | |
Charlotte U Richardson, MS, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20420 68th Ave W, Lynnwood, WA 98036 Phone: 425-431-1050 | |
Mrs. Ruth Eng, MSPA, CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20420 68th Ave W, Lynnwood, WA 98036 Phone: 425-431-1079 | |
Rachelle Zadigian, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20420 68th Ave W, Lynnwood, WA 98036 Phone: 425-431-7000 | |
Lisa M Radziwanowicz, M.C.D. CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 20420 68th Ave W, Lynnwood, WA 98036 Phone: 425-431-1069 |